| 251 |
IMRXImmuneering Corp |
Life Sciences |
0.26 |
$232M |
Unlock rating and forecasts |
| 252 |
SABSSAB Biotherapeutics, Inc. |
Life Sciences |
0.15 |
$230M |
Neutral |
-0.03% |
-0.02% |
· |
| 253 |
SIGASIGA TECHNOLOGIES INC |
Life Sciences |
0.47 |
$228M |
Unlock rating and forecasts |
| 254 |
NATRNATURES SUNSHINE PRODUCTS INC |
Life Sciences |
0.56 |
$222M |
Unlock rating and forecasts |
| 255 |
BIOABioAge Labs, Inc. |
Life Sciences |
0.44 |
$222M |
Unlock rating and forecasts |
| 256 |
LXEOLexeo Therapeutics, Inc. |
Life Sciences |
0.06 |
$217M |
Unlock rating and forecasts |
| 257 |
FATEFATE THERAPEUTICS INC |
Life Sciences |
0.12 |
$214M |
Unlock rating and forecasts |
| 258 |
GLSIGreenwich LifeSciences, Inc. |
Life Sciences |
0.11 |
$214M |
Unlock rating and forecasts |
| 259 |
KROSKeros Therapeutics, Inc. |
Life Sciences |
0.15 |
$211M |
Neutral |
+0.03% |
+0.09% |
· |
| 260 |
PLXProtalix BioTherapeutics, Inc. |
Life Sciences |
0.01 |
$211M |
Unlock rating and forecasts |
| 261 |
ALECAlector, Inc. |
Life Sciences |
0.23 |
$205M |
Unlock rating and forecasts |
| 262 |
ZNTLZentalis Pharmaceuticals, Inc. |
Life Sciences |
0.36 |
$202M |
Unlock rating and forecasts |
| 263 |
NAGENiagen Bioscience, Inc. |
Life Sciences |
0.59 |
$197M |
Neutral |
-0.28% |
-0.55% |
· |
| 264 |
RNACCartesian Therapeutics, Inc. |
Life Sciences |
0.36 |
$190M |
Unlock rating and forecasts |
| 265 |
AKBAAkebia Therapeutics, Inc. |
Life Sciences |
0.10 |
$186M |
Unlock rating and forecasts |
| 266 |
CGENCOMPUGEN LTD |
Life Sciences |
0.31 |
$185M |
Neutral |
-0.22% |
-0.41% |
· |
| 267 |
IVVDInvivyd, Inc. |
Life Sciences |
0.05 |
$182M |
Unlock rating and forecasts |
| 268 |
STROSUTRO BIOPHARMA, INC. |
Life Sciences |
0.55 |
$181M |
Unlock rating and forecasts |
| 269 |
PEPGPepGen Inc. |
Life Sciences |
0.26 |
$180M |
Unlock rating and forecasts |
| 270 |
ADCTADC Therapeutics SA |
Life Sciences |
0.29 |
$179M |
Unlock rating and forecasts |
| 271 |
ACOGAlpha Cognition Inc. |
Life Sciences |
0.62 |
$178M |
Unlock rating and forecasts |
| 272 |
ORMPORAMED PHARMACEUTICALS INC. |
Life Sciences |
0.07 |
$169M |
Unlock rating and forecasts |
| 273 |
CMPXCompass Therapeutics, Inc. |
Life Sciences |
0.17 |
$155M |
Unlock rating and forecasts |
| 274 |
CHRSCoherus Oncology, Inc. |
Life Sciences |
0.22 |
$153M |
Unlock rating and forecasts |
| 275 |
MDWDMediWound Ltd. |
Life Sciences |
0.29 |
$152M |
Neutral |
-0.30% |
-0.59% |
· |
| 276 |
UPBUpstream Bio, Inc. |
Life Sciences |
0.14 |
$151M |
Unlock rating and forecasts |
| 277 |
NBPNovaBridge Biosciences |
Life Sciences |
0.18 |
$145M |
Neutral |
-0.23% |
-0.43% |
· |
| 278 |
MOLNMOLECULAR PARTNERS AG |
Life Sciences |
0.30 |
$144M |
Unlock rating and forecasts |
| 279 |
MSLESatellos Bioscience Inc. |
Life Sciences |
0.52 |
$138M |
Unlock rating and forecasts |
| 280 |
DERMJourney Medical Corp |
Life Sciences |
0.15 |
$135M |
Unlock rating and forecasts |
| 281 |
IPHAInnate Pharma SA |
Life Sciences |
0.15 |
$134M |
Unlock rating and forecasts |
| 282 |
NKTXNkarta, Inc. |
Life Sciences |
0.03 |
$129M |
Unlock rating and forecasts |
| 283 |
ORGOOrganogenesis Holdings Inc. |
Life Sciences |
0.33 |
$129M |
Unlock rating and forecasts |
| 284 |
ANTXAN2 Therapeutics, Inc. |
Life Sciences |
0.36 |
$128M |
Unlock rating and forecasts |
| 285 |
KRROKorro Bio, Inc. |
Life Sciences |
0.13 |
$125M |
Unlock rating and forecasts |
| 286 |
ARMPArmata Pharmaceuticals, Inc. |
Life Sciences |
0.11 |
$123M |
Unlock rating and forecasts |
| 287 |
ABOSAcumen Pharmaceuticals, Inc. |
Life Sciences |
0.00 |
$122M |
Unlock rating and forecasts |
| 288 |
HUMAHumacyte, Inc. |
Life Sciences |
0.12 |
$119M |
Neutral |
+0.08% |
+0.19% |
▲ 1 |
| 289 |
OTLKOutlook Therapeutics, Inc. |
Life Sciences |
0.48 |
$119M |
Unlock rating and forecasts |
| 290 |
VYGRVoyager Therapeutics, Inc. |
Life Sciences |
0.00 |
$117M |
Unlock rating and forecasts |
| 291 |
NERVMinerva Neurosciences, Inc. |
Life Sciences |
0.14 |
$112M |
Unlock rating and forecasts |
| 292 |
ENGNenGene Therapeutics Inc. |
Life Sciences |
0.32 |
$112M |
Unlock rating and forecasts |
| 293 |
FHTXFoghorn Therapeutics Inc. |
Life Sciences |
0.12 |
$110M |
Unlock rating and forecasts |
| 294 |
HURATuHURA Biosciences, Inc./NV |
Life Sciences |
0.30 |
$107M |
Unlock rating and forecasts |
| 295 |
LENZLENZ Therapeutics, Inc. |
Life Sciences |
0.55 |
$103M |
Unlock rating and forecasts |
| 296 |
INOINOVIO PHARMACEUTICALS, INC. |
Life Sciences |
0.25 |
$102M |
Unlock rating and forecasts |